| (Values in U.S. Thousands) | Mar, 2018 | Mar, 2017 | Mar, 2016 | Mar, 2015 | Mar, 2014 |
| Sales | 244,700 | 227,220 | 218,900 | 202,590 | 171,870 |
| Sales Growth | +7.69% | +3.80% | +8.05% | +17.87% | -7.61% |
| Net Income | 27,180 | 32,720 | 31,630 | 27,330 | 14,190 |
| Net Income Growth | -16.93% | +3.45% | +15.73% | +92.60% | -48.32% |
Abaxis Inc (ABAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Their mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. The Company provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.
Fiscal Year End Date: 03/31